NTBC 2 mg (Orfadin 2 mg)
Generic Name: nitisinone
Pill with imprint NTBC 2 mg is White, Capsule-shape and has been identified as Orfadin 2 mg. It is supplied by Rare Disease Therapeutics Inc.
Orfadin is used in the treatment of hereditary tyrosinemia type 1 and belongs to the drug class miscellaneous metabolic agents. Risk cannot be ruled out during pregnancy. Orfadin 2 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for NTBC 2 mg
Orfadin
- Generic Name:
- nitisinone
- Imprint:
- NTBC 2 mg
- Strength:
- 2 mg
- Color:
- White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous metabolic agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Rare Disease Therapeutics Inc
- Inactive Ingredients:
- titanium dioxide
gelatin
Note: Inactive ingredients may vary.
More about Orfadin (nitisinone)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Support Group
- Pricing & Coupons
- En Español
- 0 Reviews – Add your own review/rating
- Drug class: miscellaneous metabolic agents
Consumer resources
- Orfadin
- Orfadin (Nitisinone Capsules)
- Orfadin (Nitisinone Oral Suspension)
- Orfadin (Advanced Reading)
Other brands: Nityr
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
